AAAAAA

   
Results: 1-8 |
Results: 8
VOROZOLE (RIVIZOR(TM)) - AN ACTIVE AND WELL TOLERATED NEW AROMATASE INHIBITOR FOR THE TREATMENT OF ADVANCED BREAST-CANCER PATIENTS WITH PRIOR TAMOXIFEN EXPOSURE
Authors: PARIDAENS R ROY JA NOOIJ M KLIJN J HOUSTON SJ BEEX LVAM VINHOLES J TOMIAK E VANVRECKEM A LANGENAEKEN C VANGLABBEKE M PICCART MJ
Citation: R. Paridaens et al., VOROZOLE (RIVIZOR(TM)) - AN ACTIVE AND WELL TOLERATED NEW AROMATASE INHIBITOR FOR THE TREATMENT OF ADVANCED BREAST-CANCER PATIENTS WITH PRIOR TAMOXIFEN EXPOSURE, Anti-cancer drugs, 9(1), 1998, pp. 29-35
THE TOLERABILITY AND ADVERSE EVENT PROFILE OF PAMIDRONATE DISODIUM
Authors: HOUSTON SJ RUBENS RD
Citation: Sj. Houston et Rd. Rubens, THE TOLERABILITY AND ADVERSE EVENT PROFILE OF PAMIDRONATE DISODIUM, Reviews in contemporary pharmacotherapy, 9(3), 1998, pp. 213-224
PALLIATION OF PAIN ASSOCIATED WITH METASTATIC BONE CANCER USING SM-153 LEXIDRONAM - A DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL-TRIAL
Authors: SERAFINI AN HOUSTON SJ RESCHE I QUICK DP GRUND FM ELL PJ BERTRAND A AHMANN FR ORIHUELA E REID RH LERSKI RA COLLIER BD MCKILLOP JH PURNELL GL PECKING AP THOMAS FD HARRISON KA
Citation: An. Serafini et al., PALLIATION OF PAIN ASSOCIATED WITH METASTATIC BONE CANCER USING SM-153 LEXIDRONAM - A DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL-TRIAL, Journal of clinical oncology, 16(4), 1998, pp. 1574-1581
THERAPEUTIC EFFECTS OF THE AROMATASE INHIBITOR FADROZOLE HYDROCHLORIDE IN ADVANCED BREAST-CANCER
Authors: BONNEFOI HR SMITH IE DOWSETT M TRUNET PF HOUSTON SJ DALUZ RJ RUBENS RD COOMBES RC POWLES TJ
Citation: Hr. Bonnefoi et al., THERAPEUTIC EFFECTS OF THE AROMATASE INHIBITOR FADROZOLE HYDROCHLORIDE IN ADVANCED BREAST-CANCER, British Journal of Cancer, 73(4), 1996, pp. 539-542
LITHIUM GAMMOLINOLENATE (LIGLA) - A NOVEL OUTPATIENT TREATMENT FOR NONRESECTABLE PANCREATIC-CARCINOMA (PC)
Authors: UNDERHILL CR HARPER PG HIGHLEY MS AHEM J BARKER SC WRIGHT CJ AHMED A HOUSTON SJ MILES DW LARVIN M MASON RC
Citation: Cr. Underhill et al., LITHIUM GAMMOLINOLENATE (LIGLA) - A NOVEL OUTPATIENT TREATMENT FOR NONRESECTABLE PANCREATIC-CARCINOMA (PC), European journal of cancer, 31A, 1995, pp. 564-564
THE SYSTEMIC TREATMENT OF BONE METASTASES
Authors: HOUSTON SJ RUBENS RD
Citation: Sj. Houston et Rd. Rubens, THE SYSTEMIC TREATMENT OF BONE METASTASES, Clinical orthopaedics and related research, (312), 1995, pp. 95-104
COMBINATION CHEMOTHERAPY WITH EPIRUBICIN, CISPLATIN AND 5-FLUOROURACIL FOR THE PALLIATION OF ADVANCED GASTRIC AND ESOPHAGEAL ADENOCARCINOMA
Authors: HIGHLEY MS PARNIS FX TROTTER GA HOUSTON SJ PENSON RT HARPER PG MASON RC
Citation: Ms. Highley et al., COMBINATION CHEMOTHERAPY WITH EPIRUBICIN, CISPLATIN AND 5-FLUOROURACIL FOR THE PALLIATION OF ADVANCED GASTRIC AND ESOPHAGEAL ADENOCARCINOMA, British Journal of Surgery, 81(12), 1994, pp. 1763-1765
THE INFLUENCE OF ADJUVANT CHEMOTHERAPY ON OUTCOME AFTER RELAPSE FOR PATIENTS WITH BREAST-CANCER
Authors: HOUSTON SJ RICHARDS MA BENTLEY AE SMITH P RUBENS RD
Citation: Sj. Houston et al., THE INFLUENCE OF ADJUVANT CHEMOTHERAPY ON OUTCOME AFTER RELAPSE FOR PATIENTS WITH BREAST-CANCER, European journal of cancer, 29A(11), 1993, pp. 1513-1518
Risultati: 1-8 |